Bioequivalence of Binimetinib 45 mg vs 3x15 mg Tablets

Phase 1, randomised, open-label trial of binimetinib in melanoma (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoints: Area Under the Plasma Concentration-time Curve From Time of Administration to Last Observed Plasma Concentration for Binimetinib, Area Under the Plasma Concentration-time Curve From Time of Administration to Infinity for Binimetinib and 1 more. Started Aug 2022; status: completed.